ArticlePloS one2026
The impact of cancer therapy-related oral complications on the quality of life and well-being of childhood cancer survivors: A scoping review.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to review the scientific literature on the effects of cancer treatment-related oral complications on the quality of life and well-being of children surviving cancer. This study updates a previous review, from 2012, evaluating the oral health related quality of life and well-being of childhood cancer survivors and exploring the extent to which children's perspectives are considered in research.
methodsWe used a scoping review methodology informed by established frameworks: Arksey and O'Malley, Levac et al. and the Joanna Briggs Institute. Articles were retrieved from five electronic databases (MEDLINE/PubMed, Scopus, Embase, Web of Science, and PsychInfo) using a predefined search strategy. Screening and study selection were performed independently by two reviewers using Rayyan software (QCRI), with a third reviewer resolving disagreements. Reporting followed the PRISMA-ScR guidelines. Inclusion criteria included articles focused on the impact of oral complications on the quality of life and well-being of child cancer survivors (aged 0-17 years at the time of diagnosis), written in English or French, and published from 2012-2025. Exclusion criteria included articles involving non-childhood cancers, and with non-specific disease categories. The protocol for this review was published in PLOS ONE (https://doi.org/10.1371/journal.pone.0290364).
results79 articles were included in this scoping review. The majority of studies had quantitative designs. In contrast to the original review, a substantial number of studies (47) reported children-reported symptoms and completed assessment tools rather than relying solely on their parents and health care providers to provide this information. Furthermore, since the original review, reporting of oral health-related quality of life (OHRQoL) measures has increased, however they were reported in a limited number of studies.
conclusionOur review suggests that there is growing implementation of patient-reported outcomes and subjective measures of OHRQoL in assessing oral complications in pediatric cancer patients. Future studies should incorporate qualitative approaches to capture children's or parents' perspectives on cancer therapy, thereby complementing quantitative findings and providing a more comprehensive understanding of the multifaceted impact of oral complications on children's quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.